A safety, tolerability, and PK study of Ent001 in patients with moderately to severely active UC

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1009618

• Contact name

  Lisa Olson

• Contact email

  info@entherapharmaceuticals.com

• Sponsor organisation

  Publication of this data is currently deferred.

• ISRCTN Number

  ISRCTN93130126

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  24/LO/0180

• Date of REC Opinion

  3 Apr 2024

• REC opinion

  Further Information Favourable Opinion